Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome
- F Bortolotti1,
- M Resti2,
- M Marcellini3,
- R Giacchino4,
- G Verucchi5,
- G Nebbia6,
- L Zancan7,
- M G Marazzi8,
- C Barbera9,
- A Maccabruni10,
- G Zuin11,
- G Maggiore12,
- F Balli13,
- P Vajro14,
- L Lepore15,
- M Molesini16,
- M Guido17,
- S Bartolacci1,
- F Noventa1,
- the Italian Observatory for Hepatitis C in children
- 1Clinica Medica 5, University of Padua, Padua, Italy
- 23rd Paediatric Clinic, Meyer Hospital, Florence, Italy
- 3Hepatologic Service, Hospital Bambin Gesù, Rome, Italy
- 4Department of Infectious Diseases, Gaslini Institute, Genoa, Italy
- 5Clinic of Infectious Diseases, Policlinico S Orsola, Bologna, Italy
- 6Paediatric Clinic De Marchi, Milan, Italy
- 7Department of Paediatrics, University of Padua, Padua, Italy
- 8Department of Infectious Diseases, Gaslini Institute, Genoa, Italy
- 9Paediatric Clinic, University of Turin, Turin, Italy
- 10Department of Infectious Diseases, Policlinico S Mattia, Pavia, Italy
- 11Department of Paediatrics, Sacco Hospital, Milan, Italy
- 12Paediatric Clinic, University of Pisa, Pisa, Italy
- 13Paediatric Clinic, University of Modena, Modena, Italy
- 14Department of Paediatrics, University Federico II, Naples, Italy
- 15Paediatric Clinic, University of Trieste, Trieste, Italy
- 16Department of Paediatrics, B Roma Hospital, Verona, Italy
- 17Department of Pathology, University of Padua, Padua, Italy
- Correspondence to:
Dr F Bortolotti
Clinica Medica 5, Via Giustiniani 2, 35100 Padova Italy; flavia.bortolotti{at}unipd.it
- Accepted 22 December 2004
- Revised 21 December 2004
Abstract
Background and aim: Little is known of hepatitis C virus (HCV) genotypes in HCV infected children. This retrospective, multicentre study investigated genotype distribution and correlation with clinical features and outcome in a large series of Italian children.
Methods: Between 1990 and 2002, 373 HCV RNA positive children, consecutively recruited in 15 centres, were assayed for genotypes by a commercial line probe assay.
Results: The following genotype distribution pattern was recorded: genotype 1b = 41%; 1a = 20%; 2 = 17%; 3 = 14.5%; 4 = 5%; other = 2.5%. The prevalence of genotypes 1b and 2 decreased significantly (p<0.001) among children born from 1990 onwards compared with older children (46% v 70%) while the rate of genotypes 3 and 4 increased significantly (from 8% to 30%). Children infected with genotype 3 had the highest alanine aminotransferase levels and the highest rate of spontaneous viraemia clearance within the first three years of life (32% v 3% in children with genotype 1; p<0.001). Of 96 children enrolled in interferon trials during the survey, 22% definitely lost HCV RNA, including 57% of those with genotypes 2 and 3.
Conclusion: HCV genotypes 1 and 2 are still prevalent among infected adolescents and young adults in Italy but rates of infection with genotypes 3 and 4 are rapidly increasing among children. These changes could modify the clinical pattern of hepatitis C in forthcoming years as children infected with genotype 3 have the best chance of spontaneous viraemia clearance early in life, and respond to interferon in a high proportion of cases.
- HCV, hepatitis C virus
- ALT, alanine aminotransferase
- IFN, interferon
- HAI, histological activity index
- IVDA, intravenous drug abuse
Footnotes
-
Conflict of interest: None declared.








